Press release
Epithelial Ovarian Cancer Market Set to Reach $4.41 Billion by 2029 with 16.1% Yearly Growth
Epithelial Ovarian CancerMarket Size
The epithelial ovarian cancer market is likely to be driven by the rising incidence of ovarian cancer. This type of cancer, which primarily originates in the ovaries and affects the epithelial cells lining the surface of these organs, is becoming increasingly prevalent due to factors like an aging population, increased awareness, improved detection techniques, as well as genetic and lifestyle factors. The treatment for epithelial ovarian cancer, the most prevalent and aggressive form of the disease, focuses on targeting malignant cells to enhance survival rates and patient outcomes. The World Ovarian Cancer Coalition, a non-profit organization based in Canada, predicted in February 2024 that the global diagnosis figures for ovarian cancer could surge by more than 55% to reach 503,448 by 2050. Moreover, annual deaths due to ovarian cancer are anticipated to increase up to 350,956, a nearly 70% hike from 2022. Hence, the escalation in ovarian cancer cases is expected to fuel the growth of the epithelial ovarian cancer market in the future.
Get Your Epithelial Ovarian Cancer Market Report Here:
https://www.thebusinessresearchcompany.com/report/epithelial-ovarian-cancer-global-market-report
What is the projected compound annual growth rate (CAGR) of the epithelial ovarian cancer market from 2025 to 2034, and what factors influence it?
The market size of epithelial ovarian cancer has seen significant growth in the past years and it is projected to expand from $2.08 billion in 2024 to $2.42 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 16.5%. Various factors have contributed to the growth in the historical period such as: greater demand for tailored cancer treatments, increased healthcare expenditure worldwide, growing preference for minimally invasive surgeries, increasing number of ovarian cancer survivors, a surge in demand for gene therapies, and expanding need for palliative care services.
The market size for epithelial ovarian cancer is predicted to experience swift expansion in the coming years. By 2029, it should reach a value of $4.41 billion, with a compound annual growth rate (CAGR) of 16.1%. This growth throughout the projected period can be linked to factors such as the rising occurrence of ovarian cancer, an aging demographic, heightened awareness about ovarian cancer, an increase in cancer research funding, and the augmentation of government interventions to fight cancer. Noteworthy trends during this period encompass advancements in medical imaging technology, the launch of novel molecular diagnostic instruments, partnerships among pharmaceutical corporations, the fast integration of AI and machine learning in diagnostic procedures, and the widened application of robotic surgeries.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20778&type=smp
How are the latest trends influencing the growth of the epithelial ovarian cancer market?
Leading firms in the epithelial ovarian cancer market are concentrating on the creation of novel treatment methods, such as FRa-specific antibody-drug conjugates (ADCs), which are tailored to target the folate receptor-alpha that is overexpressed in cancer cells. This results in the delivery of powerful cytotoxic drugs with minimal damage to healthy tissues. Essentially, an FRa-specific ADC is a targeted cancer treatment that attaches a cytotoxic drug to an antibody that is specific to the folate receptor-alpha (FRa), thus delivering the drug directly to cancer cells expressing this receptor. For example, AbbVie Inc., a biopharmaceutical corporation based in the United States, was granted approval by the European Commission in November 2024 for ELAHERE (mirvetuximab soravtansine), a targeted treatment for adult patients diagnosed with platinum-resistant, high-grade serous ovarian, fallopian tube, or primary peritoneal cancer that expresses the folate receptor-alpha (FRa). ELAHERE offers an alternative, effective treatment option for patients who have undergone up to three prior systemic regimens. It is designed to target a biomarker present in approximately one-third of ovarian cancer patients, thereby increasing survival chances and enhancing life quality. The approval also comprises a companion diagnostic tool for identifying suitable patients.
What are the major segments of the epithelial ovarian cancer market and their role in driving growth?
The epithelial ovarian cancer market covered in this report is segmented -
1) By Type Of Treatment: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Surgery
2) By Drug Class: Platinum-based Chemotherapy Drugs, Poly(ADP-ribose) Polymerase Inhibitors, Bevacizumab, Chemotherapeutic Agents
3) By Stage Of Cancer: Early Stage, Advanced Stage
4) By Diagnosis Method: Imaging, Biopsy, Blood Tests
5) By End User: Hospitals, Clinics, Diagnostic Laboratories
Subsegments:
1) By Chemotherapy: Platinum-Based Chemotherapy, Non-Platinum Chemotherapy, Combination Chemotherapy
2) By Targeted Therapy: Monoclonal Antibodies, PARP Inhibitors, Angiogenesis Inhibitors, Other Targeted Agents
3) By Immunotherapy: Checkpoint Inhibitors, Cancer Vaccines, Adoptive T-Cell Therapy
4) By Hormonal Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Progestins
5) By Surgery: Debulking Surgery, Oophorectomy, Hysterectomy, Other Surgical Procedures
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20778
Which regions are key players in the growth of the epithelial ovarian cancer market?
North America was the largest region in the epithelial ovarian cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epithelial ovarian cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the epithelial ovarian cancer market?
Major companies operating in the epithelial ovarian cancer market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Merck KGaA, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eisai Co. Ltd., Genentech Inc., Qiagen N.V., Myriad Genetics Inc., Zymeworks Inc., Novogen Limited, Karyopharm Therapeutics Inc., Clovis Oncology Inc., ImmunoGen Inc., Fujirebio Diagnostics Inc., Vivesto AB
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20778&type=smp
What Is Covered In The Epithelial Ovarian Cancer Global Market Report?
•Market Size Forecast: Examine the epithelial ovarian cancer market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the epithelial ovarian cancer market for a structured understanding.
•Key Players Overview: Analyze major players in the epithelial ovarian cancer market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the epithelial ovarian cancer market.
•Segment Contributions: Evaluate how different segments drive overall growth in the epithelial ovarian cancer market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the epithelial ovarian cancer market.
•Industry Challenges: Identify potential risks and obstacles affecting the epithelial ovarian cancer market.
•Competitive Landscape: Review strategic developments in the epithelial ovarian cancer market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epithelial Ovarian Cancer Market Set to Reach $4.41 Billion by 2029 with 16.1% Yearly Growth here
News-ID: 3944704 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
